Growth Metrics

Glucotrack (GCTK) Accumulated Expenses (2016 - 2019)

Historic Accumulated Expenses for Glucotrack (GCTK) over the last 4 years, with Q4 2019 value amounting to $401000.0.

  • Glucotrack's Accumulated Expenses fell 5628.88% to $401000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $401000.0, marking a year-over-year decrease of 5628.88%. This contributed to the annual value of $401000.0 for FY2019, which is 5628.88% down from last year.
  • Latest data reveals that Glucotrack reported Accumulated Expenses of $401000.0 as of Q4 2019, which was down 5628.88% from $552051.0 recorded in Q3 2019.
  • Glucotrack's Accumulated Expenses' 5-year high stood at $1.4 million during Q3 2018, with a 5-year trough of $363738.0 in Q4 2016.
  • For the 4-year period, Glucotrack's Accumulated Expenses averaged around $803188.4, with its median value being $878433.0 (2018).
  • As far as peak fluctuations go, Glucotrack's Accumulated Expenses soared by 15545.06% in 2017, and later plummeted by 6009.04% in 2019.
  • Glucotrack's Accumulated Expenses (Quarter) stood at $363738.0 in 2016, then surged by 155.45% to $929171.0 in 2017, then dropped by 1.27% to $917386.0 in 2018, then plummeted by 56.29% to $401000.0 in 2019.
  • Its Accumulated Expenses stands at $401000.0 for Q4 2019, versus $552051.0 for Q3 2019 and $612436.0 for Q2 2019.